Carlos Andrés Celis-Preciado's Avatar

Carlos Andrés Celis-Preciado

@pulmonology101

Pulmonologist, Fellow Airways Diseases | PhD (c) Immunology |PRISMA Lab, Université de Sherbrooke, Québec, Canada. #asthma #COPD #bronchiectasis #biomarkers

1,425
Followers
2,085
Following
16
Posts
12.11.2024
Joined
Posts Following

Latest posts by Carlos Andrés Celis-Preciado @pulmonology101

Post image

Great response to our correspondence to Clarice Leung and John Fahy on the association between FeNO and baseline membrane thickness in SARP-3. This seems like a good marker of type-2 inflammation, and more specifically IL-13 activity, in #asthma.

www.atsjournals.org/doi/abs/10.1...

04.07.2025 12:21 👍 1 🔁 1 💬 0 📌 0

📰 For #WorldAsthmaDay check out this #OpenAccess meta-analysis on inflammatory and clinical risk factors for #asthma attacks (ORACLE2)

Findings support incorporation of blood eosinophils and FeNO into clinical risk stratification

🔗 tinyurl.com/93ar3am3

@simcouillard.bsky.social

06.05.2025 11:22 👍 8 🔁 4 💬 0 📌 0
Preview
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype | NEJM Mepolizumab is a humanized monoclonal antibody that targets interleukin-5, a cytokine that plays a central role in eosinophilic inflammation, which is present in 20 to 40% of patients with chronic ...

"Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype."
Publié ce jour dans le @nejm.org.
#MedSky @simcouillard.bsky.social
www.nejm.org/doi/full/10....

01.05.2025 11:00 👍 1 🔁 2 💬 0 📌 0
A bar chart showing the change from baseline in forced vital capacity at week 52 in the overall trial population

A bar chart showing the change from baseline in forced vital capacity at week 52 in the overall trial population

In the FIBRONEER-IPF phase 3 trial, nerandomilast slowed disease progression in patients with idiopathic pulmonary fibrosis as compared with placebo. Full trial results: nej.md/4mgWcIU

#ATS2025 @atscommunity.bsky.social

18.05.2025 21:20 👍 26 🔁 10 💬 0 📌 0
Post image

🧵A new COPD diagnostic schema that includes chest imaging, respiratory symptoms, and spirometry identified more high-risk individuals and excluded low-risk ones. #ATS2025

ja.ma/4dp9i30

19.05.2025 00:21 👍 36 🔁 10 💬 1 📌 2
Post image Post image Post image

Hey #ATS2025, help us spread the word on our revolutionary person-centered framework on supplemental oxygen to improve wellbeing & independence for patients & families.

jamanetwork.com/journals/jam...

@pallipulm.bsky.social
@atscommunity.bsky.social
@jamainternalmed.com
@angelasuen.bsky.social

19.05.2025 20:01 👍 4 🔁 2 💬 0 📌 0
Lung art installation

Lung art installation

So grateful for the community and science (and 🫁 art!) at #ATS2025

19.05.2025 21:00 👍 6 🔁 1 💬 0 📌 0
Video thumbnail

A JAMA study examines a multidimensional diagnostic approach for #COPD that uses a new diagnostic schema for more individualized and inclusive COPD patient care. #ATS2025

ja.ma/3GYcUg1

19.05.2025 21:00 👍 11 🔁 2 💬 0 📌 2
Post image

Congrats to our teaching competition representative Dr. Chris Chou for winning the #ATS2025 teaching competition ✍️with his novel approach to explaining chest tube mechanics! 🫁

@ats-assemblies.bsky.social

19.05.2025 21:40 👍 3 🔁 2 💬 0 📌 0
Post image

1/ The amazing UW PCCM fellows are headed to #ATS2025! 🤩

In these challenging times, their commitment to research and improving patient care gives me hope.

@atscommunity.bsky.social
@atsearlycareer.bsky.social
@apccmpd.bsky.social

16.05.2025 19:32 👍 4 🔁 2 💬 1 📌 0

🚨 Funded Clinical Research Fellowship
Asthma/COPD focus | MSc/PhD req | 2–3 yrs | 80% research, 20% clinic | Sherbrooke, QC 🇨🇦
French is a must (95% francophone patients).
📩 S.Couillard@USherbrooke.ca
🌐 DM for details!

www.usherbrooke.ca/dep-medecine...

21.04.2025 16:06 👍 3 🔁 1 💬 0 📌 0
Preview
Inflammatory and clinical risk factors for asthma attacks (ORACLE2): a patient-level meta-analysis of control groups of 22 randomised trials Blood eosinophil count, FeNO, asthma attack history, disease severity, low lung function (low FEV1%), and symptoms (ACQ-5 score) are key predictors of asthma attacks. Conversely, we found that moderat...

🚨 Our new paper is out in The Lancet Respiratory Medicine!
ORACLE2 pooled 6,500+ #asthma patients from 22 RCTs.
🧪 Blood #eosinophils + #FeNO = key predictors of #asthma attacks
💨 Reversibility = lower risk?
Open access: www.thelancet.com/journals/lan...
#asthma #ORACLE2

09.04.2025 02:43 👍 3 🔁 0 💬 0 📌 0
Post image

🚨 New paper in @lancetrespirmed.bsky.social !
ORACLE2: we pooled data from 6,500+ asthma patients x22 RCTs.

🧪 Blood eosinophils + FeNO = powerful predictors of asthma attacks (esp. together)
💨 Surprise: more lung reversibility = lower risk?

Open access 👉 doi.org/10.1016/S221...

Global collab 💪

09.04.2025 01:39 👍 5 🔁 2 💬 0 📌 0

🚀 Exciting News! 🚀 Thrilled to share that our paper, Phenotyping the Responses to Systemic Corticosteroids in the Management of Asthma Attacks (PRISMA), has been accepted for publication in the European Respiratory Society ERJ journal! 🎉 Congratulations to 1st author @pulmonology101.bsky.social

20.02.2025 14:14 👍 3 🔁 2 💬 0 📌 0
Post image

Phenotyping Responses to Systemic Corticosteroids in the Management of #Asthma Attacks (PRISMA). Blood #eosinophils and #FeNO can stratify asthma #exacerbations, predicting better clinical responses to #OCS. @simcouillard.bsky.social @usherbrooke.bsky.social
publications.ersnet.org/content/erj/...

19.02.2025 23:30 👍 4 🔁 1 💬 0 📌 1

Apprenez en davantage sur notre projet Propulsion Santé 👉. Merci FMSQ pour le beau résumé et la visibilité. Merci AstraZeneca, Opération-Enfant-Soleil , et Association pulmonaire du Québec pour le financement ayant permis de partir un projet qui se déploie maintenant à vitesse grand V. 🚀

29.01.2025 15:28 👍 2 🔁 1 💬 0 📌 0

Honored to step into the role of Director of the Public Health Institute at Javeriana University in Bogotá.

Grateful for the journey so far and eager to drive meaningful change in public health while strengthening collaboration across Latin America and beyond.

18.01.2025 20:18 👍 68 🔁 2 💬 9 📌 0
Screenshot of a guardian article asking the question quoted in the post

Screenshot of a guardian article asking the question quoted in the post

The @theguardian.com is now wondering whether Elon Musk made a "Nazi salute" or a "Roman salute" 🤦‍♀️
Picking up any secondary school history book would be sufficient to know there is pretty much no difference - Hitler copied Mussolini

21.01.2025 19:58 👍 5 🔁 1 💬 0 📌 0
A Structured, Anatomy-Based Chest CT Interpretation Curriculum for Pulmonary Fellows Covering the Main Patterns of Parenchymal Lung Disease | MedEdPORTAL Introduction Chest computed tomography (CT) interpretation is a key competency for pulmonary fellows, with many resources intended for radiologists but very few for this specific group. We endeavored ...

This self-guided curriculum from University of Washington SOM provides a structured approach connecting key lung anatomy to patterns of disease & is an effective way to teach chest computed tomography interpretation to pulmonary fellows. www.mededportal.org/doi/10.15766... #MedEd #Medsky

14.01.2025 20:38 👍 13 🔁 3 💬 0 📌 0

@natmedicine.bsky.social is also now on Bluesky! 🎉

You can follow all of our journals with our starter pack.

09.01.2025 13:56 👍 43 🔁 11 💬 0 📌 1
Post image

How eating fiber->short-chain fatty acid (SCFA) metabolites->anti-cancer effects
nature.com/articles/s42...
nature.com/articles/s42...

09.01.2025 15:22 👍 175 🔁 40 💬 3 📌 4
Preview
Reinventing type 2 immunity in cancer - Nature This Review addresses the roles of type 2 immunity in cancer and the potential for cancer immunotherapies targeting this pathway.

"unlike type 1 immune responses, type 2 immunity is perceived as a potential promoter of tumorigenesis. Emerging evidence challenges this perspective, painting a more nuanced picture in which type 2 immunity might protect against or even actively suppress tumour growth and progression." #ImmunoSky

09.01.2025 19:15 👍 50 🔁 21 💬 1 📌 0

Grateful for the opportunity to briefly discuss the findings in our group’s @jama.com article on identifying asthma endotypes through nasal epithelial transcriptomic profiles with Dr Kristin Walter. @upmc.bsky.social @atscommunity.bsky.social

02.01.2025 22:25 👍 6 🔁 2 💬 0 📌 0

Fascinating study on pediatric #asthma endotypes (full-text link @jama.com: ja.ma/402KbwE)

#Medsky #Pedsky #PedPulmSky
@ats-peds.bsky.social

03.01.2025 01:44 👍 9 🔁 6 💬 0 📌 0

In this @jama.com article, Molin Yue+ Dr Kristina Gaietto show similar proportions of nasal epithelial transcriptomic profiles for T2-high, T17-high+ T2-low/T17-low asthma across 3 cohorts of predom. Puerto Rican+ Black youth, with T2-high less common than T2-low profiles. @atscommunity.bsky.social

02.01.2025 22:20 👍 9 🔁 4 💬 1 📌 0
Post image

🧵 Pulse oximeters overestimate arterial oxygen saturation and provide more variable readings in people with darker skin pigmentations.

Despite guidance from the @fda.gov, the reporting of participant skin tones in pulse oximeter testing has been inconsistent.

ja.ma/3DKuKBw

30.12.2024 17:42 👍 52 🔁 35 💬 2 📌 4
ChatGPT (GPT-4) versus doctors on complex cases of the Swedish family medicine specialist examination: an observational comparative study Background Recent breakthroughs in artificial intelligence research include the development of generative pretrained transformers (GPT). ChatGPT has been shown to perform well when answering several s...

🧪 While LLMs have done well in medical skill comparisons with multiple choice questions, a new study finds GPT-4 scored lower than human doctors in free-text assessments of primary care cases, highlighting its limitations in complex clinical reasoning. 🩺🖥️ #MLSky

29.12.2024 14:03 👍 84 🔁 20 💬 7 📌 7
Post image

Out now in @thetxidjournal.bsky.social!

T-SPOT.TB is more likely to produce actionable results than QFT-TB in patients with cancer being screened for latent TB.

#TxID #IDSky

onlinelibrary.wiley.com/doi/10.1111/...

28.12.2024 18:11 👍 26 🔁 7 💬 1 📌 4

🧬

28.12.2024 12:32 👍 1 🔁 0 💬 0 📌 0

A starter pack for PhD students and Postdocs in Immunology to connect 🔽

Drop a 🧬 and I'll add you to the list.
Let's build the upcoming immuno community!

#ImmunoSky 🧪

go.bsky.app/RABVXY4

04.12.2024 07:14 👍 97 🔁 58 💬 79 📌 3